Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taixiong Xue

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Pharmacological Research|September 25, 2021
Epigenetic regulation in fibrosis progressTaixiong Xue, Xingyu Qiu, Hongyao Liu, et al.
Journal of Medicinal Chemistry|March 20, 2023
Application and Study of ROCK Inhibitors in Pulmonary Fibrosis: Recent Developments and Future PerspectivesYuting Xie, Lin Yue, Yaojie Shi, et al.
Frontiers in Cell and Developmental Biology|October 8, 2021
Liver Fibrosis: Therapeutic Targets and Advances in Drug TherapyZui Tan, Hongbao Sun, Taixiong Xue, et al.
Biomarker Research|August 30, 2024
BRD4: an effective target for organ fibrosisQun Wei, Cailing Gan, Meng Sun, et al.
European Journal of Medicinal Chemistry|August 29, 2022
Discovery and evaluation of phenacrylanilide derivatives as novel potential anti-liver fibrosis agentsLin Yue, Taixiong Xue, Xingping Su, et al.
European Journal of Medicinal Chemistry|June 26, 2025
Focal adhesion kinase inhibitors in fibrotic diseases therapy: Development and therapeutic potentialCailing Gan, Wei Wei, Taixiong Xue, et al.
Bioorganic Chemistry|May 13, 2026
Design, synthesis, and biological evaluation of ALK5 PROTAC degraders for pulmonary fibrosisLin Yue, Yuting Li, Cailing Gan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 30, 2022
An oral phenylacrylic acid derivative suppressed hepatic stellate cell activation and ameliorated liver fibrosis by blocking TGF-β1 signallingTaixiong Xue, Lin Yue, Guonian Zhu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|February 28, 2026
Huangqi Guizhi Wuwu Decoction attenuates bleomycin-induced pulmonary fibrosis via modulating TGF-β/Smad and cell-cycle: Integrated transcriptomics, network pharmacology and experimental validationYuanmei Bai, Peilin Li, Cailing Gan, et al.
European Journal of Medicinal Chemistry|December 4, 2022
Discovery of the novel Benzo[b]thiophene 1,1-dioxide derivatives as a potent STAT3 inhibitor against idiopathic pulmonary fibrosisYijie Wang, Hongyao Liu, Wenzhen Li, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Pharmacological Research|September 25, 2021
Epigenetic regulation in fibrosis progressTaixiong Xue, Xingyu Qiu, Hongyao Liu, et al.
Journal of Medicinal Chemistry|March 20, 2023
Application and Study of ROCK Inhibitors in Pulmonary Fibrosis: Recent Developments and Future PerspectivesYuting Xie, Lin Yue, Yaojie Shi, et al.
Frontiers in Cell and Developmental Biology|October 8, 2021
Liver Fibrosis: Therapeutic Targets and Advances in Drug TherapyZui Tan, Hongbao Sun, Taixiong Xue, et al.
Biomarker Research|August 30, 2024
BRD4: an effective target for organ fibrosisQun Wei, Cailing Gan, Meng Sun, et al.
European Journal of Medicinal Chemistry|August 29, 2022
Discovery and evaluation of phenacrylanilide derivatives as novel potential anti-liver fibrosis agentsLin Yue, Taixiong Xue, Xingping Su, et al.
European Journal of Medicinal Chemistry|June 26, 2025
Focal adhesion kinase inhibitors in fibrotic diseases therapy: Development and therapeutic potentialCailing Gan, Wei Wei, Taixiong Xue, et al.
Bioorganic Chemistry|May 13, 2026
Design, synthesis, and biological evaluation of ALK5 PROTAC degraders for pulmonary fibrosisLin Yue, Yuting Li, Cailing Gan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 30, 2022
An oral phenylacrylic acid derivative suppressed hepatic stellate cell activation and ameliorated liver fibrosis by blocking TGF-β1 signallingTaixiong Xue, Lin Yue, Guonian Zhu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|February 28, 2026
Huangqi Guizhi Wuwu Decoction attenuates bleomycin-induced pulmonary fibrosis via modulating TGF-β/Smad and cell-cycle: Integrated transcriptomics, network pharmacology and experimental validationYuanmei Bai, Peilin Li, Cailing Gan, et al.
European Journal of Medicinal Chemistry|December 4, 2022
Discovery of the novel Benzo[b]thiophene 1,1-dioxide derivatives as a potent STAT3 inhibitor against idiopathic pulmonary fibrosisYijie Wang, Hongyao Liu, Wenzhen Li, et al.
Pageof 2